Clinical and biochemical study of 28 patients with mucopolysaccharides type VI

Clinical Genetics

Volumn 66, Issue 3, 2004, Pages 208-213

  Azevedo, A C M M ^a,b   Schwartz, I V ^a,b   Kalakun, L ^a   Brustolin, S ^a   Burin, M G ^a   Beheregaray, A P C ^a   Leistner, S ^a   Giugliani, C ^a   Rosa, M ^a   Barrios, P ^a   Marinho, D ^a   Esteves, P ^a   Valadares, E ^c   Boy, R ^d   Horovitz, D ^e   Mabe, P ^f   da Silva, L C S ^g   de Souza, I C N ^g   Ribeiro, M ^h   Martins, A M ⁱ   Palhares, D ^j   Kim, C A ^k   Giugliani, Roberto ^a,b   more..

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f UNIVERSITY OF CHILE   (Chile)

^g FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^h FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

ⁱ FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^j FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^k UNIVERSITY OF SÃO PAULO   (Brazil)

more..

Author keywords

Arylsulfatase B; Inborn errors of metabolism; Lamy syndrome; Lysosomal storage diseases; Maroteaux; Mucopolysaccharidoses; Mucopolysaccharidosis type VI

Indexed keywords

GLYCOSAMINOGLYCAN; N ACETYLGALACTOSAMINE 4 SULFATASE;

ADOLESCENT; ARTICLE; BIOCHEMISTRY; BIRTH WEIGHT; BODY HEIGHT; BRAZIL; CARBOHYDRATE ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONSANGUINITY; CONTROLLED STUDY; CORNEA OPACITY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; EPIDEMIOLOGICAL DATA; FEMALE; FREQUENCY ANALYSIS; HEART DISEASE; HUMAN; INTERVIEW; LEUKOCYTE; MALE; MAROTEAUX LAMY SYNDROME; MEDICAL LITERATURE; MORBIDITY; ONSET AGE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SHORT STATURE; URINARY EXCRETION; VISUAL SYSTEM EXAMINATION;

BRAZIL; CHILD, PRESCHOOL; CHILE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GLYCOSAMINOGLYCANS; HUMANS; INTERVIEWS; MUCOPOLYSACCHARIDOSIS VI; N-ACETYLGALACTOSAMINE-4-SULFATASE; PHENOTYPE;

EID: 4544354475     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2004.00277.x     Document Type: Article

References (23)

1. Nyhan WL, Ozand PT. Maroteux-Lamy disease/mucopolysaccharidosis VI (MPS VI)/N-acetylgalactosamine-4-sulfatase deficiency. In: Atlas of metabolic diseases, 1a edn (Nyhan WL, Ozand PT, eds). London: Chapman & Hall Medical, 1998: p477-p481.
2. Auclair D, Hopwood JJ, Brooks DA, Lemontt JF, Crawley AC. Replacement therapy in mucopolysaccharidosis type VI: advantages of early of therapy. Mol Genet Metab 2003: 78: 163-174.
3. Litjens T, Baker EG, Beckmann KR, Morris CP, Hopwood JJ, Callen DF. Chromosomal localization of ARSB, the gene for human N-acetylgalactosamine-4-sulfatase. Hum Genet 1989: 82 (1): 67-68.
4. Peters C, Schmidt B, Rommerskirch W. Phylogenetic conservation of arylsulfatases; cDNA cloning and expression of human arylsulfatase B. J Biol Chem 1990: 265: 3374-3381.
5. Bradford MT, Litjens T, Parkinson EJ, Hopwood JJ, Brooks DA. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine-4-sulfatase at multiple points in the vacuolar network. Biochemistry 2002: 41 (15): 4962-4971.
6. Wicker G, Prill V, Brooks D et al. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) an intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B. J Biol Chem 1991: 266: 21386-21391.
7. Wraith JE. The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child 1996: 72: 263-267.
8. Beck M. Mucopolysaccharidoses and oligosaccharidoses. In: Inborn metabolic diseases, diagnosis and treatment, 3rd edn (Fernandes J, Saudubray M, Van der Berghe G, eds). New York: Springer, 2000: p415-p421.
9. Schwartz IVD, Matte US, Leistner S, Giugliani R. Mucopolissacaridoses. In: Doenças genéticas em pediatria, 1a edn (Carakushanski G, ed). Rio de Janeiro: Guanabara Koogan, 2001: p180-p184.
10. De Jong JCN, Wevers RA, Liebrand-van Sambeek R. Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin Chem 1992: 38: 803-807.
11. Kresse H, von Fugura K, Klein U, Glossi J, Paschke E, Pohlmann R. Enzimic diagnosis of genetic mucopolissaccharide storage disorders. Methods Enzymol 1982: 83: 559-572.
12. Hamil PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center of Health Statistics percentiles. Am J Clin Nutr 1979: 32: 607-629.
13. Nelhaus G. Head circumference from birth to eighteen years: practical composite international and interracial graphs. Pediatr 1968: 41: 106-114.
14. Liascovich R, Rittler M, Castilla EE. Consanguinity in South America: demographic aspects. Hum Hered 2001: 1151: 27-34.
15. Alves-Silva J, Santos MS, Guimarães PEM et al. The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 2000: 67: 444-461.
16. Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr 1967: 71 (2): 159-163.
17. Pinheiro CEA. Peso ao nascer na espécie humana: um enfoque multifatorial [Dissertação de Mestrado]. Porto Alegre: Universidade Federal do Rio Grande do Sul, 1989: p214.
18. Neufeld EF, Muenzer J. The mucopolysaccharidosis. In: The metabolic and molecular basis of inherited disease, 8a edn (Scriver CR, Beandet AL, Sly S, Valle D, Childs B, Kinzler KW, Volgelstein B, eds). New York: McGraw-Hill, 2001: p3421-p3452.
19. Gomes UA, Silva AA, Bettiol H, Barbieri MA. Risk factors for the increasing caesarean section rate in Southeast Brazil: a comparison of two birth cohorts, 1978-1979 and 1994. Int J Epidemiol 1999: 28 (4): 687-694.
20. Boor R, Miebach E, Brühl K, Beck M. Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses. Neuropediatrics 2000: 31: 122-127.
21. Thorne JA, Javadpour M, Hughes DG, Wraith E, Cowie RA. Craniovertebral abnormalities in type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 2001: 48 (4): 849-853.
22. Mabe P, Leistner S, Schwartz I, Matte U, Giugliani R. Mucopolisacaridosis. In: Errores innatos en el matabolismo del niñ o, 2a edn (Colombo M, Cornejo V, Raimann E, eds). Santiago de Chile: Editora Universitária, 2003: p225-p256.
23. Dangel JH. Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders - clinical and echocardiographic findings in 64 patients. Eur J Pediatr 1998: 157: 534-538.